Abstract
Sleep disturbances are common in chronic obstructive pulmonary disease (COPD) and are often associated with sleep disordered breathing in the form of nocturnal oxygen desaturation, obstructive sleep apnea (OSA), and hypoventilation. The respiratory changes during sleep in COPD have profound effects on sleep quality and quality of life. In addition, the physiologic alterations that result from the disordered breathing likely aggravate certain COPD-related complications, such as pulmonary hypertension, and possibly may increase mortality. Recently, the focus on specific clinical phenotypes such as upper lobe predominant emphysema, frequent exacerbators, and presence of peripheral muscle dysfunction have advanced the approaches to therapy that are affecting outcomes. It is likely that patients with coexistent COPD and sleep disordered breathing (the overlap syndrome) define another clinical phenotype that have a significant impact on the natural history of the disease. Studies have shown a high prevalence of OSA among patients with COPD and that such patients have a higher mortality despite treatment. This effect could perhaps be mediated via mechanisms involving comorbidities, including cardiovascular disease and metabolic syndromes. Current interventions, like supplemental oxygen, positive airway pressure support, and lung volume reduction improve the well being and survival of some patients with COPD, but the optimal therapy for the COPD overlap phenotype remains to be determined.
Keywords: Overlap syndrome, chronic obstructive pulmonary disease, sleep apnea, chronic bronchitis, emphysema, hypoventilation
Current Respiratory Medicine Reviews
Title: Chronic Obstructive Pulmonary Disease and Sleep Disordered Breathing - The Overlap Syndrome: An Evolving Clinical Phenotype
Volume: 6 Issue: 2
Author(s): Christopher Halpin, Samuel Krachman and Wissam Chatila
Affiliation:
Keywords: Overlap syndrome, chronic obstructive pulmonary disease, sleep apnea, chronic bronchitis, emphysema, hypoventilation
Abstract: Sleep disturbances are common in chronic obstructive pulmonary disease (COPD) and are often associated with sleep disordered breathing in the form of nocturnal oxygen desaturation, obstructive sleep apnea (OSA), and hypoventilation. The respiratory changes during sleep in COPD have profound effects on sleep quality and quality of life. In addition, the physiologic alterations that result from the disordered breathing likely aggravate certain COPD-related complications, such as pulmonary hypertension, and possibly may increase mortality. Recently, the focus on specific clinical phenotypes such as upper lobe predominant emphysema, frequent exacerbators, and presence of peripheral muscle dysfunction have advanced the approaches to therapy that are affecting outcomes. It is likely that patients with coexistent COPD and sleep disordered breathing (the overlap syndrome) define another clinical phenotype that have a significant impact on the natural history of the disease. Studies have shown a high prevalence of OSA among patients with COPD and that such patients have a higher mortality despite treatment. This effect could perhaps be mediated via mechanisms involving comorbidities, including cardiovascular disease and metabolic syndromes. Current interventions, like supplemental oxygen, positive airway pressure support, and lung volume reduction improve the well being and survival of some patients with COPD, but the optimal therapy for the COPD overlap phenotype remains to be determined.
Export Options
About this article
Cite this article as:
Halpin Christopher, Krachman Samuel and Chatila Wissam, Chronic Obstructive Pulmonary Disease and Sleep Disordered Breathing - The Overlap Syndrome: An Evolving Clinical Phenotype, Current Respiratory Medicine Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339810791171232
DOI https://dx.doi.org/10.2174/157339810791171232 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Subpopulations of Bone Marrow Mesenchymal Stem Cells Exhibit Differential Effects in Delaying Retinal Degeneration
Current Molecular Medicine Thyrotoxic Periodic Paralysis: A Concise Review of the Literature
Current Rheumatology Reviews Drug in Adhesive Transdermal Formulation of Valsartan and Nifedipine: Pharmacokinetics and Pharmacodynamics in Rats
Current Drug Therapy Angiotensin II and Abdominal Aortic Aneurysms: An update
Current Pharmaceutical Design Editorial: Perioperative Pharmacological Management: From Prescription Medications to Dietary Supplements
Current Clinical Pharmacology Monitoring Kidney Function in Neuroendocrine Tumor Patients Treated with <sup>90</sup>Y-DOTATOC: Associations with Risk Factors
Current Radiopharmaceuticals Current Management of Traumatic Rupture of the Descending Thoracic Aorta
Current Cardiology Reviews Reactions of 4-(Diethylamino)selenet-2(2H)-imine with Nucleophiles – Synthesis of 2-Methylen-3-oxobutane Selenoamides
Letters in Organic Chemistry Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Current Vascular Pharmacology Preface [Hot topic: Modern Aspects in the Design And Discovery of Novel Antihypertensive Drugs (Guest Editor: Thomas Mavromoustakos)]
Current Topics in Medicinal Chemistry The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer
Current Drug Targets Formulation and Assessment of In Vivo Anti-Inflammatory Potential of Omega-3-Fatty Acid Loaded Self Emulsifying Nanoemulsion
Current Nanomedicine Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life Data from Boceprevir or Telaprevir based “Triple Therapy” Experience in Southern Italy
Reviews on Recent Clinical Trials Adult Neurogenesis and the Diseased Brain
Current Medicinal Chemistry Aortic Arch Calcification and Mortality in Chronic Hemodialysis Patients
Reviews on Recent Clinical Trials Fetal Determinants of Type 2 Diabetes
Current Drug Targets Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Editorial [Hot Topic:Dietary Determinants of the Metabolic Syndrome (Guest Editor: Luc Tappy Co-Editors: Jacques Delarue and Kim-Anne Le)]
Current Nutrition & Food Science Electrochemical Behavior of Indole-3-Carboxaldehyde Izonicotinoyl Hydrazones: Discussion on Possible Biological Behavior
Combinatorial Chemistry & High Throughput Screening Electrocardiogram in Andersen-Tawil Syndrome. New Electrocardiographic Criteria for Diagnosis of Type-1 Andersen-Tawil Syndrome
Current Cardiology Reviews